What actually happens between the intake form and the pharmacy: state licensing rules, evaluation standards, timelines, and what a legitimate platform never skips.
A GLP-1 online prescription works like this: you complete a medical intake on a telehealth platform, a provider licensed in your state reviews it — by asynchronous review or a video visit, depending on state law — and if you meet the clinical criteria, they issue a prescription within 24 to 72 hours, sent to a pharmacy that ships to your door. It is a fully legal process governed by the same licensing rules as an in-person visit.
The reason online prescribing dominates GLP-1 access in 2026 is fit: the medications follow standardized eligibility criteria, structured titration schedules, and predictable monitoring — exactly the kind of care telehealth handles well. But the system only works when the platform follows the rules, so knowing what a compliant evaluation looks like protects you from the sellers who merely imitate one.
Telehealth prescribing is legal in every state, under two non-negotiable conditions. First, the prescriber must hold an active license in the state where you are located — not just any state. Legitimate platforms maintain networks of clinicians across all the states they serve and route your intake accordingly. Second, a valid patient-provider relationship must be established before prescribing, which means a genuine medical evaluation: some states accept asynchronous review of your written intake, others require a synchronous video or phone visit.
GLP-1 medications are not controlled substances, which keeps them clear of the stricter federal rules governing online prescribing of controlled drugs. What the law never permits is dispensing without any prescription at all — the line that separates telehealth from the gray market we dissect in the no-prescription explainer.
The intake is the foundation of the prescription, and its thoroughness is your first quality signal. Expect structured questions on: height and weight for BMI calculation, weight history and prior loss attempts, current medications and supplements, personal and family medical history — with specific screens for thyroid cancer history and pancreatitis — plus digestive conditions, pregnancy status, and mental health context.
Treat the intake as a medical record rather than a form to pass. Platforms cross-check answers — a medication list inconsistent with the conditions you report triggers manual review and slows the decision. The applicants who move through in 24 hours are the ones whose files are complete, consistent, and specific: exact medication names and doses, real dates for diagnoses, honest side-effect history from any previous GLP-1 use. There is no advantage to strategic vagueness; providers decline unclear files far more often than imperfect ones. If your situation is complicated, say so in the free-text fields — context routes you to the right level of review instead of a reflexive decline.
Free online assessment · licensed providers · plans from $199/mo
Behind the scenes, a licensed clinician evaluates your intake against the standard criteria — BMI of 30 or higher, or 27 with a weight-related condition — and screens for contraindications. In asynchronous states, this happens in writing, often with follow-up questions through the platform's messaging. In synchronous states, you book a short video visit, typically 10 to 20 minutes, covering the same ground conversationally.
Three outcomes are possible. Approval, with a specific medication and titration plan. A request for more information — commonly recent labs or clarification on a flagged condition. Or a decline, which reputable platforms deliver with an explanation rather than a silent rejection; a decline from one legitimate evaluator based on safety criteria will generally repeat elsewhere, and shopping around for a yes is a signal to reconsider rather than persist. Unsure where you stand before starting? The two-minute assessment previews the same criteria.
The standard cadence in 2026 runs as follows. Intake completion: day zero. Provider review: 24 to 72 hours for asynchronous states; video-visit states add scheduling time, usually one to five days depending on platform capacity. Prescription transmission to pharmacy: same day as approval. Fulfillment: brand medication through NovoCare, LillyDirect, or a retail pharmacy arrives in two to seven business days; compounded medication adds compounding time, typically landing three to seven business days after the prescription.
End to end, most approved patients hold medication within one to two weeks of first click — dramatically faster than the typical primary care path of a booked appointment weeks out, a separate pharmacy trip, and a possible prior authorization cycle. The channel-by-channel speed comparison sits in our three-channel comparison.
A GLP-1 prescription is the start of a monitored process, not a one-off transaction. Titration means dose increases roughly every four weeks, and legitimate programs gate each increase behind a check-in — a message exchange or short visit reviewing side effects, weight trend, and tolerance. Refills follow the same rhythm, which is why all-inclusive programs at $99 to $299 per month for compounded semaglutide bundle the ongoing provider access into the price.
Your responsibilities are simple but real: report side effects honestly, keep weigh-ins current, reorder about a week before running out, and store medication refrigerated. Platforms differ most in this after-care layer — response time to messages, ease of reaching a human clinician, flexibility on pausing or adjusting doses — and it is worth weighing those factors as heavily as price when choosing where to start.
Free online assessment · licensed providers · plans from $199/mo
Getting a GLP-1 Prescription Online
Take a free online assessment with a licensed provider — approval in minutes, medication delivered to your door.
Find My GLP-1 Pen